Suppr超能文献

功能丧失是早发性冠状动脉疾病的一个相关危险因素:一项病例对照研究。

Loss-of-Function is an Associated Risk Factor for Premature Coronary Artery Disease: A Case-Control Study.

作者信息

Chen Wenhao, Liu Yuanliang, Deng Xunwei, Li Bin, Wang Hao, Wei Guoliang, Chen Kehui, Wang Shen

机构信息

Center for Cardiovascular Diseases, Meizhou People's Hospital, Meizhou, People's Republic of China.

Department of Computer Tomography, Meizhou People's Hospital, Meizhou, People's Republic of China.

出版信息

Int J Gen Med. 2024 Nov 3;17:5049-5058. doi: 10.2147/IJGM.S486187. eCollection 2024.

Abstract

OBJECTIVE

Cytochrome P450 2C19 (CYP2C19) is a major enzyme involved in the biotransformation and metabolism of various substances. Loss-of-function of the gene represents downregulation of CYP2C19 enzyme indication limited or no enzymatic function, which may be, in turn, associated with some disease susceptibility. The relationship between polymorphisms and susceptibility to premature coronary artery disease (PCAD) is not fully understood. This study aimed to assess this relationship.

METHODS

This study included 635 PCAD patients, and 548 age-matched non-CAD individuals as controls, from November 2019 to August 2023. The rs4244285 (681G > A, *2) and rs4986893 (636G > A, *3) were genotyped, and the distribution of polymorphisms between patients and controls and the relationship between polymorphisms and PCAD risk were analyzed.

RESULTS

A total of 442 (37.4%), 543 (45.9%), and 198 (16.7%) individuals had extensive metabolizer (EM) (*1/*1), intermediate metabolizer (IM) (*1/*2 and *1/*3), and poor metabolizer (PM) (*2/*2, *2/*3, and *3/*3) phenotypes, respectively. *2/*2 genotype frequency was higher, *1/*1 genotype was lower in PCAD patients than controls. Individuals with PM phenotype had higher triglyceride (TG) levels than those with EM or IM phenotypes. Logistic regression analysis showed that body mass index (BMI) ≥24.0 kg/m (≥24.0 kg/m vs 18.5-23.9 kg/m, odds ratio (OR): 1.326, 95% confidence interval (CI): 1.041-1.688, = 0.022), smoking (OR: 1.974, 95% CI: 1.283-3.306, = 0.002), hypertension (OR: 1.327, 95% CI: 1.044-1.687, = 0.021), diabetes mellitus (OR: 1.390, 95% CI: 1.054-1.834, = 0.020), PM phenotype (PM phenotype vs EM phenotype, OR: 1.701, 95% CI: 1.200-2.411, = 0.003), and IM+PM phenotypes (IM+PM vs EM phenotype, OR: 1.369, 95% CI: 1.077-1.740, = 0.010) were associated with PCAD.

CONCLUSION

PM or IM+PM phenotypes, overweight, smoking, hypertension, and diabetes mellitus were associated with PCAD.

摘要

目的

细胞色素P450 2C19(CYP2C19)是参与多种物质生物转化和代谢的主要酶。该基因功能丧失代表CYP2C19酶下调,表明酶功能有限或无酶功能,这反过来可能与某些疾病易感性相关。CYP2C19基因多态性与早发性冠状动脉疾病(PCAD)易感性之间的关系尚未完全明确。本研究旨在评估这种关系。

方法

本研究纳入了2019年11月至2023年8月期间的635例PCAD患者以及548例年龄匹配的非CAD个体作为对照。对rs4244285(681G>A,*2)和rs4986893(636G>A,*3)进行基因分型,并分析患者与对照之间CYP2C19基因多态性的分布以及CYP2C19基因多态性与PCAD风险之间的关系。

结果

分别有442例(37.4%)、543例(45.9%)和198例(16.7%)个体具有广泛代谢型(EM)(*1/*1)、中间代谢型(IM)(*1/2和1/*3)和慢代谢型(PM)(*2/*2、*2/3和3/3)表型。PCAD患者中2/*2基因型频率较高,*1/*1基因型频率低于对照。PM表型个体的甘油三酯(TG)水平高于EM或IM表型个体。逻辑回归分析显示,体重指数(BMI)≥24.0 kg/m²(≥24.0 kg/m² 与18.5 - 23.9 kg/m²相比,比值比(OR):1.326,95%置信区间(CI):1.041 - 1.688,P = 0.022)、吸烟(OR:1.974,95% CI:1.283 - 3.306,P = 0.002)、高血压(OR:1.327,95% CI:1.044 - 1.687,P = 0.021)、糖尿病(OR:1.390,95% CI:1.054 - 1.834,P = 0.020)、PM表型(PM表型与EM表型相比,OR:1.701,95% CI:1.200 - 2.411,P = 0.003)以及IM + PM表型(IM + PM与EM表型相比,OR:1.369,95% CI:1.077 -

相似文献

1
Loss-of-Function is an Associated Risk Factor for Premature Coronary Artery Disease: A Case-Control Study.
Int J Gen Med. 2024 Nov 3;17:5049-5058. doi: 10.2147/IJGM.S486187. eCollection 2024.
2
Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients.
Int J Gen Med. 2023 Aug 14;16:3473-3481. doi: 10.2147/IJGM.S420108. eCollection 2023.
5
Apolipoprotein E E3/E4 genotype is associated with an increased risk of premature coronary artery disease.
BMC Cardiovasc Disord. 2024 Jul 10;24(1):353. doi: 10.1186/s12872-024-04021-8.
8
Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis.
J Stroke Cerebrovasc Dis. 2022 Nov;31(11):106798. doi: 10.1016/j.jstrokecerebrovasdis.2022.106798. Epub 2022 Oct 7.
9
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia.
Eur J Vasc Endovasc Surg. 2019 Sep;58(3):373-382. doi: 10.1016/j.ejvs.2019.02.011. Epub 2019 Aug 5.
10
Sex differences in the impact of CYP2C19 polymorphisms and low-grade inflammation on coronary microvascular disorder.
Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1494-500. doi: 10.1152/ajpheart.00911.2015. Epub 2016 Mar 18.

引用本文的文献

2
Association of c.681G>A (rs4244285) Loss-of-function Allele with Cardiovascular Disease Risk in the Kosovo Population.
Balkan J Med Genet. 2025 Mar 6;27(2):77-85. doi: 10.2478/bjmg-2024-0015. eCollection 2024 Dec.

本文引用的文献

1
Clopidogrel resistance and its relevance: Current concepts.
J Family Med Prim Care. 2024 Jun;13(6):2187-2199. doi: 10.4103/jfmpc.jfmpc_1473_23. Epub 2024 Jun 14.
3
Targeting the apelin system for the treatment of cardiovascular diseases.
Cardiovasc Res. 2023 Dec 30;119(17):2683-2696. doi: 10.1093/cvr/cvad171.
4
*2/*2 Genotype is a Risk Factor for Multi-Site Arteriosclerosis: A Hospital-Based Cohort Study.
Int J Gen Med. 2023 Nov 6;16:5139-5146. doi: 10.2147/IJGM.S437251. eCollection 2023.
6
Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients.
Int J Gen Med. 2023 Aug 14;16:3473-3481. doi: 10.2147/IJGM.S420108. eCollection 2023.
9
Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation.
Eur Heart J. 2023 Jun 1;44(21):1874-1889. doi: 10.1093/eurheartj/ehad170.
10
Ethnic differences in the lifestyle behaviors and premature coronary artery disease: a multi-center study.
BMC Cardiovasc Disord. 2023 Mar 29;23(1):170. doi: 10.1186/s12872-023-03192-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验